A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ATS International Conference. The drug, called AD109, is the first therapy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results